跳到正文
收录说明
收录范围
保留计量方法研究、相关统计基础,以及实质涉及计量方法的应用、教程、比较和综述。书评、刊务及明确无关内容不公开;身份或相关性证据不足的记录保留待核,补充可靠材料后可重新判断。
当前期刊来源见下方官网链接及期刊目录。综合经济学与金融期刊逐篇筛查计量方向,证据不足时暂不公开。正刊、在线优先论文和已核实接收稿合并展示;按标题、可靠摘要、目录及身份匹配的出版社 JEL 分类核验相关性;计量类 JEL 与摘要相互印证,无 JEL 不直接排除。历史回补以可取得的注册题录和目录为准,不等于覆盖全部纸本。
日期与排序
默认按最近发表排序:正刊使用刊期,待刊使用上线日期;缺少上线日期时,排序参考登记或首次收录时间,并在卡片注明。更多筛选可选择出版状态和日期口径;卷期依据出版社元数据,不因待刊时间较长而推定已编入正刊。仅有月份或年份时,日期区间相交也会纳入。

日期精度:到日 5 篇 · 到月 1 篇 · 到年 0 篇

分类与引用
领域和方法依据题名、摘要初步分类,可人工修正;分类不代表论文质量。引用数采用 OpenAlex 单条关联记录,不合计版本。
更新与 AI 解读
正常题录、可靠摘要与引用同步继续;日、周、月简报按核实的发表与修订日期汇总,历史补录保留在文献库。AI 解读依据可靠摘要或已核实原文片段,已有解读保留供阅读参考;缺少可靠材料的条目保持待解读,浏览页面不会触发生成。
6 篇论文
导出

Augmented balancing weights as linear regression

作为线性回归的增广平衡权重

Abstract We provide a novel characterization of augmented balancing weights, also known as automatic debiased machine learning. These popular doubly robust estimators combine outcome modelling with balancing weights—weights that achieve covariate balance directly instead of estimating and inverting the propensity score. When the outcome and weighting models are both linear in some (possibly infinite) basis, we show that the augmented estimator is equivalent to a single…

AI 解读阅读原文 ↗BibTeX ↓

Nonparametric Tests of Treatment Effect Homogeneity for Policy-Makers

面向政策制定者的处理效应同质性非参数检验

Recent work has focused on nonparametric estimation of conditional treatment effects, but inference has remained relatively unexplored. We propose a class of nonparametric tests for both quantitative and qualitative treatment effect heterogeneity. The tests can incorporate a variety of structured assumptions on the conditional average treatment effect, allow for both continuous and discrete covariates, and do not require sample splitting to obtain a tractable asymptotic null…

AI 解读阅读原文 ↗BibTeX ↓

Generalizing the Intention-to-Treat Effect of an Active Control from Historical Placebo-Controlled Trials: A Case Study of the Efficacy of Daily Oral TDF/FTC in the HPTN 084 Study

从历史安慰剂对照试验推广活性对照的意向治疗效应:HPTN 084 案例

In many clinical settings, an active-controlled trial design (e.g., a non-inferiority or superiority design) is often used to compare an experimental medicine to an active control (e.g., an FDA-approved, standard therapy). One prominent example is a recent phase 3 efficacy trial, HIV Prevention Trials Network Study 084 (HPTN 084), comparing long-acting cabotegravir, a new HIV pre-exposure prophylaxis (PrEP) agent, to the FDA-approved daily oral tenofovir disoproxil fumarate…

AI 解读阅读原文 ↗BibTeX ↓

Proximal mediation analysis

近端中介分析

Summary A common concern when trying to draw causal inferences from observational data is that the measured covariates are insufficiently rich to account for all sources of confounding. In practice, many of the covariates may only be proxies of the latent confounding mechanism. Recent work has shown that in certain settings where the standard no-unmeasured-confounding assumption fails, proxy variables can be leveraged to identify causal effects. Results currently exist for…

AI 解读阅读原文 ↗BibTeX ↓

Inference for treatment effect parameters in potentially misspecified high-dimensional models

可能误设的高维模型中处理效应参数的推断

Summary Eliminating the effect of confounding in observational studies typically involves fitting a model for an outcome adjusted for covariates. When, as often, these covariates are high-dimensional, this necessitates the use of sparse estimators, such as the lasso, or other regularization approaches. Naïve use of such estimators yields confidence intervals for the conditional treatment effect parameter that are not uniformly valid. Moreover, as the number of covariates…

AI 解读阅读原文 ↗BibTeX ↓

Discussion of Kallus and Mo, Qi, and Liu: New Objectives for Policy Learning

对 Kallus 及 Mo、Qi、Liu 的讨论:政策学习的新目标

One of the key contributions that the causal inference literature has brought is a focus on clearly defined estimands. This focus has led to a real shift in the statistical approach (see, e.g., Dan...

AI 解读阅读原文 ↗BibTeX ↓